At a glance
ClinicalIndex Comparison RecordN/ACompleted· 144 enrolled
Drug / intervention
MIRCERAother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis
In Brief
An observational study evaluating MIRCERA for Anemia. Completed, enrolled 144 participants across 20 sites.
Detailed Summary
An observational, longitudinal, multi-center, non-interventional study in participants with chronic kidney disease (CKD) stage 3-4, assessed by Modification of Diet in Renal Disease (MDRD) to collect data regarding safety and efficacy in participants with pre-dialysis situation who are treated with MIRCERA in normal clinical environment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
Primary CompletionApr 2011
First PostedOct 2015
TodayJul 2026
First PostedOct 2, 2015
Enrollment StartApr 1, 2009
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.8 years ago
Interventions
MIRCERAother